More Novartis layoffs

Share this article:

Novartis is continuing its cost-cutting streak. Reuters reports that the drugmaker is planning on cutting and relocating up to 4,000 jobs, according to an internal email held by newspaper NZZ am Sonntag.

Sunday's news follows a spate of other layoffs at the drugmaker, including the recent closure of an Ontario, Canada, plant, and the company's decision to shake off some California jobs and move others to Massachusetts.

Reuters says this latest round will inflict pink slips on around 6% of employees in the Swiss drug maker's pharmaceutical division and that “a significant number” of jobs will be moved to Hyderabad, India, as part of a consolidation strategy.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.